Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. CERTNAS Other Certification by the Nasdaq Stock Market
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. 8-A12B Other Registration of Securities
  14. S-1/A Offering Registration Statement
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. S-1/A Offering Registration Statement
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-1 Offering Registration Statement
  19. DRSLTR Other Correspondence Related to Draft Registration Statement
  20. DRS/A Other Draft Registration Statement

Page 29 of 30 · 584 filings